BOSTON--(BUSINESS WIRE)--Ora, Inc., the world’s leading Clinical Research Organization (CRO) for ophthalmology pharmaceutical and device development, announced today its partnership with the ...

2024 /PRNewswire/ -- Ora, Inc., the world's leading partner for ophthalmic pharmaceutical and device development, today announced its participation as a major exhibitor in the Association for ...

A media Snippet accompanying this announcement is available by clicking on this link. BOSTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Today we celebrate the launch of The Blind Canvas Project, using the ...

The History of Parliament Trust unveils new publication at Palace of Westminster BOSTON, September 06, 2023--(BUSINESS WIRE)--Ora, Inc., the world’s leading Clinical Research Organisation (CRO ...

BOSTON--(BUSINESS WIRE)--#ARVO2023--Ora, Inc. supports eye care innovators across every phase of drug and device development to help bring their life-changing therapies to patients. Completely ...

Ora booth #1630 at ARVO to highlight Blind Canvas Project, which creates AI-assisted artistic renderings of the lived experiences of the visually impaired "Team Ora is thrilled to be heading to ...

This innovative, diverse and global project is a collaboration between the world’s leading ophthalmology clinical trial research organization, Ora, Inc., and BlindCAN Film Festival, a team of ...

2024 /PRNewswire/ -- Ora, Inc., the world's leading partner for ophthalmic pharmaceutical and device development, today announced its participation as a major exhibitor in the Association for Research ...